Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045) Meeting Abstract
| Authors: | Hwang, E.; Kilburn, L.; Mitchell, D.; Lin, T.; Poussaint, T. Y.; Robinson, G.; Gajjar, A.; Lenzen, A.; Dorris, K.; Robison, N.; Fangusaro, J.; Fouladi, M.; Onar-Thomas, A.; Dunkel, I. |
| Abstract Title: | Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045) |
| Meeting Title: | 29th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 26 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2024 Nov 21-24 |
| Meeting Location: | Houston, TX |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-11-01 |
| Start Page: | viii85 |
| End Page: | viii86 |
| Language: | English |
| ACCESSION: | WOS:001362580000031 |
| DOI: | 10.1093/neuonc/noae165.0339 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CTIM-06 (Citation ID: NOAE165.0339) -- Source: Wos |
